Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-06

FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved Ascend Laboratories' original application for a generic fixed-dose combination tablet of dapagliflozin and metformin hydrochloride for the trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin and metformin hydrochloride (dapagliflozin and metformin hydrochloride)

Snippet

ORIG AP for DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE)